These distinct roles of E2F1 in the presence and the absence of SETD6 might explain previous findings pointing toward a conflicting role of E2F1 in prostate cancer [82], because in the light of our findings the effects of E2F1 on tumor progression depend on the SETD6 expression level of the cancer cell. Here, SETD6 is linked to prostate carcinoma.